# Yellow Fever Virus Vaccine and Immune Globulin Study

> **NCT00254826** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 80 (actual)

## Conditions studied

- Viremia

## Interventions

- **BIOLOGICAL:** YF-VAX® plus saline
- **BIOLOGICAL:** 17D YF Vaccine plus Ig,

## Key facts

- **NCT ID:** NCT00254826
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2013-12-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00254826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00254826, "Yellow Fever Virus Vaccine and Immune Globulin Study". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00254826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*